First appearance of Crohn's disease following infliximab treatment for spondylarthropathy

Emmanuel Tsochatzis 2nd Department of Internal Medicine, Hippokration General Hospital, Athens, Greece

Dimitrios Vassilopoulos 2nd Department of Internal Medicine, Hippokration General Hospital, Athens, GreeceCorrespondence[email protected]

, MD,

Emanuel K. Manesis 2nd Department of Internal Medicine, Hippokration General Hospital, Athens, Greece

George Papatheodoridis 2nd Department of Internal Medicine, Hippokration General Hospital, Athens, Greece

Ageliki Bousiotou Department of Pathology, Hippokration General Hospital, Athens, Greece

Emilia Hadziyannis 2nd Department of Internal Medicine, Hippokration General Hospital, Athens, Greece

Athanasios J. Archimandritis 2nd Department of Internal Medicine, Hippokration General Hospital, Athens, Greece

show all

References

Cominelli F. Cytokine-based therapies for Crohn's disease: new paradigms. N Engl J Med 2004; 351: 2045–8
PubMed Web of Science ®Google Scholar
Cobrin GM, Abreu MT. Defects in mucosal immunity leading to Crohn's disease. Immunol Rev 2005; 206: 277–95
PubMed Web of Science ®Google Scholar
Cho JH. Advances in the genetics of inflammatory bowel disease. Curr Gastroenterol Rep 2004; 6: 467–73
PubMedGoogle Scholar
Oh J, Arkfeld DG, Horwitz DA. Development of Crohn's disease in a patient taking etanercept. J Rheumatol 2005; 32: 752–3
PubMedGoogle Scholar
Marzo-Ortega H, McGonagle D, O'Connor P, Emery P. Efficacy of etanercept for treatment of Crohn's related spondyloarthritis but not colitis. Ann Rheum Dis 2003; 62: 74–6
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

First appearance of Crohn's disease following infliximab treatment for spondylarthropathy

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

First appearance of Crohn's disease following infliximab treatment for spondylarthropathy

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date